Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Game-Changing DNA Forensics Technology

by Global Biodefense Staff
September 25, 2014
ExactID DNA Forensics from Battelle

Every year, investigators collect tens of thousands of biological samples from crime scenes that may hold valuable clues to solving criminal cases.

Unlocking those clues now is easier thanks to a revolutionary new software solution unveiled today by Battelle experts who have applied advanced bioinformatics to next-generation sequencing data.

ExactID, the first commercially available system of its kind, analyzes biomarkers that can predict physical appearance, ancestry, clinical traits and familial relationships among people. This information can be invaluable to forensic analyses and case work.

An explosion of genetic research since the completion of the Human Genome Project in 2006 has uncovered thousands of biomarkers that can be applied to DNA-based forensics. Next generation sequencing takes this work to a new level, yielding significantly more information than current DNA testing.

What exactly does this mean? Suppose detectives are seeking a suspect but don’t have any conclusive identifying information. If they can obtain a DNA sample, perhaps from something like a discarded cigarette, they can uncover useful facts that can aid in his or her capture, or inform the larger investigation. By using ExactID, forensic scientists can determine features and traits from the biomarkers present in the DNA–such specifics as the man has blond hair and green eyes, is Caucasian and may be related to people who live in Hoboken, NJ. Such information could be vitally important for solving an investigative puzzle.

The ExactID software is low cost, fast and easy to use, making it accessible to law enforcement at all levels.

“Next-generation sequencing is the most significant breakthrough in forensic DNA science in 20 years,” said Rich Guerrieri, Research Leader for Battelle’s Applied Genomics business unit and former Chief of the FBI Laboratory’s nuclear DNA casework and database units. “ExactID is the result of years of research by Battelle and marks a new era of investigative genetics.”

Battelle will demonstrate ExactID at the International Symposium on Human Identification (ISHI) conference Sept. 29–Oct. 2 in Phoenix, AZ.

Battelle is an official sponsor of Global Biodefense. ExactID is a trademarked, protected term of Battelle.

Tags: BattelleBioinformaticsBiomarkersForensics

Related Posts

small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC